Touchlight

At Touchlight, we have developed a novel synthetic DNA vector (dbDNA™) and an enzymatic manufacturing process that enables us to produce DNA with unprecedented speed, scale, and purity. Utilizing our patented enzymatic DNA production platform, we support partners driving the advancement of genetic medicine.We provide contract development and manufacturing capabilities to produce dbDNA™ as a critical starting material and active pharmaceutical ingredient for advanced therapies, such as DNA and mRNA vaccines, as well as cell and gene therapies. We are collaborating with over 50 biotech and large pharmaceutical companies and deploying our dbDNA™ technology to develop our own gene medicine products.